Ivermectin in dermatology: why it ‘mite’ be useless against COVID‐19
Open Access
- 25 April 2021
- journal article
- letter
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 46 (7) , 1327-1328
Abstract
Dear Editor, Misinformation has been a major global challenge in the COVID‐19 pandemic. Several therapies relevant to dermatology have been falsely touted as beneficial, including hydroxychloroquineKeywords
This publication has 3 references indexed in Scilit:
- Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19JAMA, 2021
- Shedding light on the myths of ultraviolet radiation in the COVID‐19 pandemicClinical and Experimental Dermatology, 2020
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitroAntiviral Research, 2020